Upgrade to SI Premium - Free Trial

Lexaria Bioscience (LEXX)

0.53 -0.02 (3.64%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/17/26)

Latest Headlines

Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule June 25, 2026 9:10 AM - StreetInsider Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule June 23, 2026 9:25 AM - StreetInsider GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand June 17, 2026 9:26 AM - StreetInsider Lexaria begins animal study on next-generation GLP-1 drugs June 9, 2026 9:25 AM - StreetInsider Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway June 9, 2026 9:25 AM - StreetInsider Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program June 3, 2026 9:25 AM - StreetInsider Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7 May 19, 2026 9:15 AM - StreetInsider Lexaria Bioscience Releases Second Episode of Investor Video Series May 7, 2026 9:26 AM - StreetInsider Lexaria advances human study testing oral semaglutide formulations May 5, 2026 9:11 AM - StreetInsider Lexaria Updates Progress on Human Study #7 May 5, 2026 9:10 AM - StreetInsider Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications May 1, 2026 9:25 AM - StreetInsider Lexaria extends pharmaceutical partnership through december 2026 April 29, 2026 9:10 AM - StreetInsider Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended April 29, 2026 9:10 AM - StreetInsider Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs April 23, 2026 9:06 AM - StreetInsider Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales April 21, 2026 9:10 AM - StreetInsider Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property April 15, 2026 9:14 AM - StreetInsider Form 10-Q Lexaria Bioscience Corp. For: Feb 28 April 13, 2026 1:08 PM - SEC Filing Lexaria notes FDA approval of Eli Lilly's oral weight-loss drug Foundayo April 7, 2026 9:10 AM - StreetInsider Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval April 7, 2026 9:10 AM - StreetInsider Lexaria signs contracts for human study of oral semaglutide formulation April 1, 2026 9:20 AM - StreetInsider Lexaria to Begin New Human Clinical Study in GLP-1 April 1, 2026 9:20 AM - StreetInsider Full Article List